-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Sanara MedTech, Maintains $36 Price Target

Benzinga·01/26/2026 18:40:14
Listen to the news
HC Wainwright & Co. analyst Yi Chen reiterates Sanara MedTech (NASDAQ:SMTI) with a Buy and maintains $36 price target.